BSE Live
Dec 04, 11:14Prev. Close
182.10
Open Price
182.05
Bid Price (Qty.)
181.40 (124)
Offer Price (Qty.)
181.60 (18)
NSE Live
Dec 04, 11:14Prev. Close
182.05
Open Price
182.48
Bid Price (Qty.)
181.44 (760)
Offer Price (Qty.)
181.48 (14)
| Cash Flow of Piramal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 13 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 911.14 | 507.62 | 130.65 | 436.70 | 668.55 | |
| Net CashFlow From Operating Activities | 548.77 | 358.29 | 71.52 | 255.20 | 34.72 | |
| Net Cash Used In Investing Activities | -549.98 | -635.52 | -435.05 | -1,223.02 | -4,382.89 | |
| Net Cash Used From Financing Activities | -61.74 | 451.38 | 290.12 | 905.74 | 4,494.16 | |
| Foreign Exchange Gains / Losses | -1.98 | 0.37 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -64.93 | 174.52 | -73.41 | -62.08 | 145.99 | |
| Cash And Cash Equivalents Begin of Year | 228.80 | 54.28 | 127.69 | 146.73 | 0.74 | |
| Cash And Cash Equivalents End Of Year | 163.87 | 228.80 | 54.28 | 84.65 | 146.73 |
12.11.2025
Piramal Pharma Standalone September 2025 Net Sales at Rs 1,127.26 crore, down 12.23% Y-o-Y
06.11.2025
Piramal Pharma Consolidated September 2025 Net Sales at Rs 2,043.72 crore, down 8.83% Y-o-Y
05.11.2025
Piramal Pharma posts Rs 99 crore loss in Q2FY26 weighed down by CDMO business
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y